Fundraising FoxACatechol
Santa Barbara, US · Founded 2016 · Delaware corporation
Find your way into ACatechol
Sign up to find every way you can get introduced to ACatechol
- Your email: who you already know at ACatechol, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ACatechol team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
ACatechol develops bioinspired surface treatment technologies to prevent infections in medical devices, particularly catheters, by inhibiting biofilm formation. The company serves hospitals and medical device manufacturers seeking to reduce catheter-related bloodstream infections and sepsis.
Founders & leadership
ACatechol was founded in 2016 by Kollbe Ando Ahn.
Board
Reported raises · per SEC filings
Form D private placements$400K disclosed across 1 round · 2016
▶$400KraisedFeb 2016 · 2 investors · Other TechnologyRule 506(b)
- Jin-Soo AhnExecutive Officer, Director
- Eric Cook RyanDirector
- Byung-Jun AhnExecutive Officer, Director
- Offering amount
- $400K
- Amount sold
- $400K
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $273.5K |
| National Science Foundation | Phase I | 2020 | $255.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does ACatechol do?
- ACatechol develops bioinspired surface treatment technologies to prevent infections in medical devices, particularly catheters, by inhibiting biofilm formation. The company serves hospitals and medical device manufacturers seeking to reduce catheter-related bloodstream infections and sepsis.
- Who founded ACatechol?
- ACatechol was founded by Kollbe Ando Ahn in 2016.
- How much funding has ACatechol raised?
- ACatechol has disclosed $400K raised across 1 round.
- Where is ACatechol headquartered?
- ACatechol is headquartered in Santa Barbara, US.